NovoCure Limited (NVCR)

NovoCure Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-177.65	-168.63	-207.04	-92.53	-58.35	19.81
Depreciation & Amortization	12.17	9.87	9.7	9.57	9.17	7.75
Other Amortization	5.14	5.14	4.59	4.35	4.42	5.91
Asset Writedown & Restructuring Costs	3.29	1.16	0.49	0.96	0.65	0.43
Loss (Gain) From Sale of Investments	-28.27	-28.27	-26.4	-4.83	-0.24	-1.25
Stock-Based Compensation	147.77	160.04	115.61	106.96	94.9	75.72
Other Operating Activities	3.26	-2.02	0.07	-5.47	3.14	-0.7
Change in Accounts Receivable	-32.85	-26.36	29.41	2.55	5.27	-30.35
Change in Inventory	-0.25	2.57	-8.92	-4.34	2.48	-2.94
Change in Accounts Payable	30.87	19.11	14.87	14.26	27.78	25.47
Change in Other Net Operating Assets	2.05	1.04	-5.71	-0.67	-6.46	-0.7
Operating Cash Flow	-34.48	-26.37	-73.34	30.79	82.76	99.15
Operating Cash Flow Growth	-	-	-	-62.80%	-16.53%	272.46%
Capital Expenditures	-30.69	-42.86	-27.09	-21.36	-24.17	-14.97
Investment in Securities	109.43	-97.39	211.24	-118.6	-120.66	-457.88
Investing Cash Flow	78.74	-140.24	184.15	-139.96	-144.83	-472.85
Long-Term Debt Issued	-	96.92	-	-	-	558.44
Long-Term Debt Repaid	-	-12.91	-0.01	-0.03	-0.03	-150.03
Net Debt Issued (Repaid)	99.98	84.01	-0.01	-0.03	-0.03	408.41
Issuance of Common Stock	10.86	6.31	15.8	15.52	25.73	31.8
Financing Cash Flow	110.84	90.32	15.79	15.49	25.7	440.21
Foreign Exchange Rate Adjustments	0.34	-0.17	0.13	-0.1	-0.19	0.25
Net Cash Flow	155.44	-76.47	126.73	-93.78	-36.56	66.76
Free Cash Flow	-65.17	-69.22	-100.43	9.43	58.59	84.18
Free Cash Flow Growth	-	-	-	-83.90%	-30.40%	421.72%
Free Cash Flow Margin	-10.15%	-11.44%	-19.72%	1.75%	10.95%	17.03%
Free Cash Flow Per Share	-0.59	-0.64	-0.94	0.09	0.57	0.77
Cash Interest Paid	10.94	7.71	0.01	0.04	0.1	8.69
Cash Income Tax Paid	28.65	23.46	13.67	5.48	3.11	-3.26
Levered Free Cash Flow	25.42	9.29	-1.98	51.76	104.89	66.98
Unlevered Free Cash Flow	30.19	11.99	-3.21	50.55	103.7	73.45
Change in Working Capital	-0.19	-3.65	29.66	11.8	29.07	-8.52

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q